Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Pharmacology

Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis

Eva E. Nagiec, Luping Wu, Steve M. Swaney, John G. Chosay, Daniel E. Ross, Joan K. Brieland, Karen L. Leach
Eva E. Nagiec
2Department of Cardiovascular Cellular and Molecular Pharmacology, Pfizer, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luping Wu
1Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve M. Swaney
1Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John G. Chosay
1Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel E. Ross
1Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan K. Brieland
1Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen L. Leach
1Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: karen.l.leach@pfizer.com
DOI: 10.1128/AAC.49.9.3896-3902.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Structures of oxazolidinones linezolid and eperezolid.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Linezolid and eperezolid inhibit rat heart mitochondrial protein synthesis. Mitochondrial protein synthesis was carried out in isolated rat heart mitochondria as described in Materials and Methods in the presence or absence of varying concentrations of linezolid ▪ or eperezolid ▾. Results shown are the average of duplicate determinations in one experiment; error bars show the range.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Eperezolid inhibits the growth of human K562 cells. K562 cells were incubated in the presence or absence of varying concentrations of eperezolid, and cell counts were monitored as described in Materials and Methods. A. Cells were treated with the following: ▪, vehicle (0.5% DMSO); ▴, 1.7 μM; ▾, 5 μM; ⧫, 15 μM; •, 45 μM; □, 135 μM; or Δ, 400 μM eperezolid. B. K562 cells were incubated with varying concentrations of eperezolid, and cell proliferation was monitored by cell counts after 120 h.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Growth inhibition by eperezolid is reversible. K562 cells were grown in the presence of ▪, vehicle (0.5% DMSO); ▾, 15 μM eperezolid; or •, 30 μM eperezolid for 72 h. Cells were then washed in RPMI media and replated in media containing ▪, vehicle (0.5% DMSO); ▾, 15 μM eperezolid; ▴, vehicle (15 μM eperezolid recovery); •, 30 μM eperezolid; or ⧫, vehicle (30 μM eperezolid recovery) and cultured for an additional 5 days. Results shown are the average of triplicate determinations, and error bars show the standard errors of the means.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Eperezolid decreases mitochondrial Cox-1 protein levels. K562 cells were treated with vehicle (0.5% DMSO), 100 μM chloramphenicol, or varying concentrations of eperezolid for 5 days, and mitochondria were isolated. Aliquots of mitochondrial protein (10 μg) were electrophoresed on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to polyvinylidene difluoride membranes, and probed with an antibody to Cox-1 (top gel). The blot was stripped and reprobed with an antibody to Tom-20 (bottom gel). Lane 1, vehicle; 2, 3.1 μM eperezolid; 3, 6.2 μM eperezolid; 4, 12 μM eperezolid; 5, 25 μM eperezolid; 6, 50 μM eperezolid; 7, 100 μM eperezolid; 8, 100 μM chloramphenicol. The 30-kDa and 40-kDa molecular mass markers are designated on the left.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Eperezolid inhibits cell proliferation in 143B cells but not in rho zero cells. Parent 143B (A) or rho zero (B) cells were incubated with □, vehicle (0.5% DMSO); ▪, 3 μM eperezolid; ▴, 10 μM eperezolid; ▾, 100 μM eperezolid; •, 1.7 μM etoposide; ⋄, 1.75 μM cycloheximide; or ○, 30 μM chloramphenicol, and cells were counted at 48, 72, 96, and 120 h.

PreviousNext
Back to top
Download PDF
Citation Tools
Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis
Eva E. Nagiec, Luping Wu, Steve M. Swaney, John G. Chosay, Daniel E. Ross, Joan K. Brieland, Karen L. Leach
Antimicrobial Agents and Chemotherapy Aug 2005, 49 (9) 3896-3902; DOI: 10.1128/AAC.49.9.3896-3902.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis
Eva E. Nagiec, Luping Wu, Steve M. Swaney, John G. Chosay, Daniel E. Ross, Joan K. Brieland, Karen L. Leach
Antimicrobial Agents and Chemotherapy Aug 2005, 49 (9) 3896-3902; DOI: 10.1128/AAC.49.9.3896-3902.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cell proliferation
Mitochondria, Heart
Oxazoles
Protein Synthesis Inhibitors

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596